Hematodiaphyseal dysplasia of Gosal

Hematodiaphyseal dysplasia of Gosal (HDG) is a rare inherited disorder of bone development that results in abnormalities in the long tubular bones. Children and adolescents with the disorder experience bone deformities that can lead to a variety of consequences, including movement problems, disability, and pain. HDG is caused by a disruption in the process of osteogenesis and often results in increased bone fragility, making patients more susceptible to fractures and secondary complications such as infections.

History of the disease and interesting historical facts

Hematodiaphyseal dysplasia of Gosal was first described in 1979 by Indian orthopedist Dr. N. Gosal, who noted specific manifestations of this disease in his patient. Over the past decades, researchers have conducted a lot of work devoted to the study of the pathogenesis and genetic nature of GDDG. The ability to identify the disease in the early stages made it possible to track its epidemiological distribution and a deeper understanding of the mechanisms that cause bone tissue development disorders. Continuity of clinical observations and studies of various variants of GDDG manifestations are of great importance, which allows for the development of specialized approaches to diagnosis and treatment.

Epidemiology

The prevalence of Gosal hematodiaphyseal dysplasia is quite limited, and the exact statistics vary depending on the region and ethnic group. According to the latest data, the incidence in the population is approximately 1 in 1,000,000 live births. It is known that GDDG is more common in children of Indian and Arab descent, which may indicate a high level of consanguineous marriages and, accordingly, an increase in the frequency of gene mutations. Also, according to a study conducted in 2020, a correlation was found with certain geographic regions, indicating possible environmental factors contributing to the development of the disease.

Genetic predisposition to this disease

Hematodiaphyseal dysplasia of Gosal is associated with mutations in genes responsible for collagen synthesis and bone growth. In most cases, the disease is caused by mutations in the COL1A1 gene, which encodes the alpha chain of type I collagen. Research shows that more than 80% cases of GDDG are associated with an autosomal dominant inheritance pattern, suggesting that one mutated allele may be sufficient to cause the disease. An important area of research remains the exclusion of other genetic diseases that may present with similar symptoms and require different treatment approaches.

Risk factors for the development of this disease

There are certain risk factors that may influence the likelihood of developing Gosal's hematodiaphyseal dysplasia:

• Hereditary predisposition - the presence of cases of the disease in the family.
• Consanguineous marriages increase the risk of genetic abnormalities.
• Environmental factors – exposure to certain chemicals during pregnancy.
• The impact of physical activity - injuries and stress on the muscles and skeletal system can aggravate the manifestation of symptoms.

It is important to note that not all individuals with these factors will necessarily develop GDD, but they may increase the risk of developing it.

Diagnosis of this disease

The diagnosis of Gosal's hematodiaphyseal dysplasia includes several main stages:

Main symptoms:

• Deformation of bones, especially long tubular bones.
• Pain syndrome in the area of affected bones.
• Problems with mobility and coordination.
• Frequent fractures without apparent traumatic causes.

Laboratory tests:

• General and biochemical blood analysis to assess inflammatory processes and metabolism.
• Genetic testing to confirm mutations associated with the disease.

Radiological examinations:

• Radiography to detect bone deformities and structure.
• CT and MRI for detailed analysis of bone tissue condition.

Other types of diagnostics:

• Ultrasound of soft tissues to assess the condition of surrounding structures.
• Bone biopsy in rare cases for further analysis.

It is important to conduct differential diagnosis with other dysplasias and diseases of the musculoskeletal system, such as osteogenesis imperfecta, Charcot-Marie-Tooth disease and others.

Treatment

Treatment of Gosal's hematodiaphyseal dysplasia includes both conservative and surgical methods:

General treatment:

• Lifestyle correction with minimization of injuries and overloads.
• Physiotherapy to improve muscle tone and mobility.

Pharmacological treatment:

• Painkillers to reduce pain.
• Drugs to improve bone metabolism - bisphosphonates (eg, alendronate).

Surgical treatment:

• Operations to correct deformities and stabilize bones.
• Fixation of fractures using bone rods or implants.

Other types of treatment:

• Rehabilitation programs after surgical interventions.
• Psychological support and social counseling for patients' families.

List of medications used to treat this disease

• Alendronate
• Ibuprofen
• Paracetamol
• Tramadol
• Calcium carbonate

Disease monitoring

Monitoring the condition of patients with Gosal's hematodiaphyseal dysplasia includes regular examinations by specialists and monitoring of the condition of bone tissue. It is necessary to take into account:

Control stages:

• Regular X-rays to assess disease progression.
• Monitoring calcium and vitamin D levels in the blood.

Forecast:

• With adequate treatment and rehabilitation, the prognosis for life can be good, but limitations in movement are possible.
• Some patients may experience chronic pain and disability.

Complications:

• Frequent fractures.
• Regional inflammatory processes (osteomyelitis).
• Psychological difficulties associated with disability.

Age-related features of the disease

Gosal's hematodiaphyseal dysplasia can occur in different age groups, and the nature of symptoms may change over time:

• In children: the greatest attention should be paid to the early stages – the presence of fractures and bone deformations.
• Adolescents: may experience decreased physical activity and psycho-emotional disturbances.
• Adults: More likely to suffer serious consequences of the disease, including disability and chronic pain.

Questions and Answers

• What are the main symptoms that may indicate GDD? The main symptoms include bone deformities, pain, frequent fractures and problems with mobility.
• How to diagnose the disease? Diagnosis includes radiography, genetic testing, and evaluation of the patient's clinical history.
• What are the treatments for GDDG? Treatment includes conservative methods (pain relief, rehabilitation) and surgical intervention to correct deformities.
• What is the likelihood of inheriting the disease? GDDG has an autosomal dominant inheritance pattern, which increases the risk of manifestations in offspring.
• How to monitor the condition of a patient with GDD? Regular orthopedic examinations, radiographs and monitoring of blood mineral levels are recommended.

Advice from Dr. Oleg Korzhikov

Dr. Oleg Korzhikov recommends that parents and patients pay attention to the following aspects in the presence of Gosal's hematodiaphyseal dysplasia:

— Monitor your child’s physical activity, avoid excessive stress and falls.
— Get regular medical check-ups and stay in touch with your doctor.
— Pay attention to your child’s psycho-emotional state, support him in difficult times.
— Use multivitamin complexes containing vitamin D and calcium to strengthen bones.

This approach will help improve the quality of life of patients with GDDG and minimize possible complications of the disease.